-
June 11, 2021 MORE Companies to UPLIST On NASDAQ? Compass Pathways Trial Results & More (CMPS, FTRP, MYCO, CYBN) 🚀Compass Pathways (CMPS:NASDAQ) published amazing COMP360 Psilocybin Study results that will serve as support for...
-
June 10, 2021 MindMed’s CEO RESIGNS! What’s NEXT for MMED / MNMD Stock? [ My Thoughts? ]MindMed Changes CEO? Hey Guys! What a day it has been! Today, MindMed (MMED :NEO),...
-
June 9, 2021 MindMed Added To The Russell 3000 and The MSCI Canada Index [Where Does MNMD/MMED Go From Here?]MindMed (NASDAQ: MNMD), (MMED: NEO) has been added to two major indexes; the Russell 3000...
-
June 8, 2021 Will MAPS IPO? The FIRST American Psychedelic ETF (PSY), New LSD Studies & MoreThere were LOTS of general news important for the psychedelic industry as a whole and...
-
June 8, 2021 Field Trip Health Begins Trading on TSE, Sets Sights on NasdaqPsychedelic lifestyle brand Field Trip Health is now trading on the Toronto Stock Exchange under...
-
June 7, 2021 GH Research Is Taking Psychedelic 5-MeO-DMT ‘Toad Venom’ PublicGH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued...
-
June 7, 2021 AI Tech-Led Psychedelic Therapy Platform Nue Life Health Raises $3.3 MillionNue Life Health is a new therapy platform relying on AI and music as well...
-
June 4, 2021 Psychedelic Business Spotlight: June 4, 2021This week in psychedelic business: Mindset Pharma's new research, synthetic ibogaine, and the Western Hemisphere...
-
June 4, 2021 How Do our Genes Affect an LSD TRIP?? New MindMed Study [ MMED / MNMD ]Does our Genetic makeup influence our LSD trip? Hey psychedelic Investors! MindMed ( MMED/MNMD/MMQ )...
-
June 3, 2021 HAVN’s Cluster Headache Treatment BETTER Than Mindmed’s? (HAVN CEO Interview)HAVN VS. Mindmed - Whose Cluster Headache Treatment Is Better? Havn Life Sciences, (CSE: HAVN...